BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1968950)

  • 1. Effects of cross-linking on clearance of circulating alpha-fibrin monomer and its complexes.
    Shainoff JR; Dardik BN
    J Lab Clin Med; 1990 Mar; 115(3):314-23. PubMed ID: 1968950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The circulatory half-lives of alpha-profibrin and alpha-fibrin monomer, and comparisons with other fibrin(ogen) derivatives.
    Shainoff JR; DiBello PM
    Thromb Haemost; 2003 Jan; 89(1):48-52. PubMed ID: 12540953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils.
    Mosesson MW; Siebenlist KR; Hainfeld JF; Wall JS
    J Struct Biol; 1995; 115(1):88-101. PubMed ID: 7577232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen A alpha and gamma-chain dimers as potential differential indicators of atherosclerotic and thrombotic vascular disease.
    Shainoff JR; Valenzuela R; Urbanic DA; DiBello PM; Lucas FV; Graor R
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):499-503. PubMed ID: 1983461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-linked alpha s gamma t-chain hybrids in plasma clots studied by 1D- and 2D electrophoresis and western blotting.
    Grøn B; Filion-Myklebust C; Bjørnsen S; Haidaris P; Brosstad F
    Thromb Haemost; 1993 Sep; 70(3):438-42. PubMed ID: 8259545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic characterization of a saturable pathway for rapid clearance of circulating fibrin monomer.
    Dardik BN; Shainoff JR
    Blood; 1985 Mar; 65(3):680-8. PubMed ID: 3971045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa.
    Mosher DF; Schad PE
    J Clin Invest; 1979 Sep; 64(3):781-7. PubMed ID: 38260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPR-phoresis, a novel approach to determining fibrin monomer and other macromolecular derivatives of fibrinogen and fibrin in blood.
    Shainoff JR; Urbanic DA; DiBello PM; Valenzuela V
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):87-92. PubMed ID: 8457658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation.
    Murtaugh PA
    Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and metabolic properties of human asialofibrinogen.
    Martinez J; Palascak J; Peters C
    J Lab Clin Med; 1977 Feb; 89(2):367-77. PubMed ID: 833473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.
    Mimuro J; Kimura S; Aoki N
    J Clin Invest; 1986 Mar; 77(3):1006-13. PubMed ID: 2419360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin.
    Schwartz ML; Pizzo SV; Hill RL; McKee PA
    J Clin Invest; 1971 Jul; 50(7):1506-13. PubMed ID: 5090065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-assembly of soluble unlinked and cross-linked fibrin oligomers.
    Rosenfeld MA; Leonova VB; Biryukova MI; Vasileva MV
    Biochemistry (Mosc); 2011 Oct; 76(10):1155-63. PubMed ID: 22098241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of self-assembly of soluble fibrin oligomers and the role of fibrinopeptides A and B in this process].
    Rozenfel'd MA; Gershkovich KB; Kuznetsov DV; Meshkov BB; Gontar' ID
    Mol Biol (Mosk); 1986; 20(4):1098-110. PubMed ID: 3762532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of blood coagulation factor XIIIa-mediated cross-linking between fibronectin and collagen by polyamines.
    Mosher DF; Schad PE; Kleinman HK
    J Supramol Struct; 1979; 11(2):227-35. PubMed ID: 548650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.